GJB1 and peripheral neuropathy: Other gene replacement studies in inherited peripheral neuropathies, such as CMTX1, where lentiviral delivery of wild-type GJB1 showed therapeutic benefit, have underlined the potential of this technique, but have also highlighted the complexity of translating these strategies to clinical use [68].